BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 21527531)

  • 1. Constitutive Notch pathway activation in murine ZMYM2-FGFR1-induced T-cell lymphomas associated with atypical myeloproliferative disease.
    Ren M; Cowell JK
    Blood; 2011 Jun; 117(25):6837-47. PubMed ID: 21527531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Src activation plays an important key role in lymphomagenesis induced by FGFR1 fusion kinases.
    Ren M; Qin H; Ren R; Tidwell J; Cowell JK
    Cancer Res; 2011 Dec; 71(23):7312-22. PubMed ID: 21937681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IRAK1-regulated IFN-γ signaling induces MDSC to facilitate immune evasion in FGFR1-driven hematological malignancies.
    Cai B; Liu Y; Chong Y; Zhang H; Matsunaga A; Fang X; Pacholczyk R; Zhou G; Cowell JK; Hu T
    Mol Cancer; 2021 Dec; 20(1):165. PubMed ID: 34906138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic fingerprinting of the development and progression of T-cell lymphoma in a murine model of atypical myeloproliferative disorder initiated by the ZNF198-fibroblast growth factor receptor-1 chimeric tyrosine kinase.
    Ren M; Li X; Cowell JK
    Blood; 2009 Aug; 114(8):1576-84. PubMed ID: 19506298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 14-3-3 Integrates prosurvival signals mediated by the AKT and MAPK pathways in ZNF198-FGFR1-transformed hematopoietic cells.
    Dong S; Kang S; Gu TL; Kardar S; Fu H; Lonial S; Khoury HJ; Khuri F; Chen J
    Blood; 2007 Jul; 110(1):360-9. PubMed ID: 17389761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct stem cell myeloproliferative/T lymphoma syndromes induced by ZNF198-FGFR1 and BCR-FGFR1 fusion genes from 8p11 translocations.
    Roumiantsev S; Krause DS; Neumann CA; Dimitri CA; Asiedu F; Cross NC; Van Etten RA
    Cancer Cell; 2004 Mar; 5(3):287-98. PubMed ID: 15050920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling the human 8p11-myeloproliferative syndrome in immunodeficient mice.
    Agerstam H; Järås M; Andersson A; Johnels P; Hansen N; Lassen C; Rissler M; Gisselsson D; Olofsson T; Richter J; Fan X; Ehinger M; Fioretos T
    Blood; 2010 Sep; 116(12):2103-11. PubMed ID: 20554971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 8p12 stem cell myeloproliferative disorder: the FOP-fibroblast growth factor receptor 1 fusion protein of the t(6;8) translocation induces cell survival mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt/mTOR pathways.
    Guasch G; Ollendorff V; Borg JP; Birnbaum D; Pébusque MJ
    Mol Cell Biol; 2001 Dec; 21(23):8129-42. PubMed ID: 11689702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder.
    Chen J; Deangelo DJ; Kutok JL; Williams IR; Lee BH; Wadleigh M; Duclos N; Cohen S; Adelsperger J; Okabe R; Coburn A; Galinsky I; Huntly B; Cohen PS; Meyer T; Fabbro D; Roesel J; Banerji L; Griffin JD; Xiao S; Fletcher JA; Stone RM; Gilliland DG
    Proc Natl Acad Sci U S A; 2004 Oct; 101(40):14479-84. PubMed ID: 15448205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of the plasminogen activator inhibitor-2 in cells expressing the ZNF198/FGFR1 fusion kinase that is involved in atypical myeloproliferative disease.
    Kasyapa CS; Kunapuli P; Hawthorn L; Cowell JK
    Blood; 2006 May; 107(9):3693-9. PubMed ID: 16410451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of ZMYM2-FGFR1 driven AML in human CD34+ cells in immunocompromised mice.
    Ren M; Qin H; Wu Q; Savage NM; George TI; Cowell JK
    Int J Cancer; 2016 Aug; 139(4):836-40. PubMed ID: 27005999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ponatinib suppresses the development of myeloid and lymphoid malignancies associated with FGFR1 abnormalities.
    Ren M; Qin H; Ren R; Cowell JK
    Leukemia; 2013 Jan; 27(1):32-40. PubMed ID: 22781593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic application of next-generation sequencing in ZMYM2-FGFR1 8p11 myeloproliferative syndrome: A case report.
    Wang Y; Wu X; Deng J; Yu H; Xu R; Zhu Z; Tu S; Hu Y
    Cancer Biol Ther; 2016 Aug; 17(8):785-9. PubMed ID: 27415155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-339 Promotes Development of Stem Cell Leukemia/Lymphoma Syndrome via Downregulation of the
    Hu T; Chong Y; Lu S; Wang R; Qin H; Silva J; Kitamura E; Chang CS; Hawthorn L; Cowell JK
    Cancer Res; 2018 Jul; 78(13):3522-3531. PubMed ID: 29735550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of the SSBP2 and ABL proteins by the ZNF198-FGFR1 fusion kinase seen in atypical myeloproliferative disorders as revealed by phosphopeptide-specific MS.
    Kasyapa C; Gu TL; Nagarajan L; Polakiewicz R; Cowell JK
    Proteomics; 2009 Aug; 9(16):3979-88. PubMed ID: 19658100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The homeoprotein Dlx5 drives murine T-cell lymphomagenesis by directly transactivating Notch and upregulating Akt signaling.
    Tan Y; Sementino E; Xu J; Pei J; Liu Z; Ito TK; Cai KQ; Peri S; Klein-Szanto AJ; Wiest DL; Testa JR
    Oncotarget; 2017 Feb; 8(9):14941-14956. PubMed ID: 28122332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGFR1 fusion kinase regulation of MYC expression drives development of stem cell leukemia/lymphoma syndrome.
    Hu T; Wu Q; Chong Y; Qin H; Poole CJ; van Riggelen J; Ren M; Cowell JK
    Leukemia; 2018 Nov; 32(11):2363-2373. PubMed ID: 29720732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical individual roles of the BCR and FGFR1 kinase domains in BCR-FGFR1-driven stem cell leukemia/lymphoma syndrome.
    Chong Y; Liu Y; Lu S; Cai B; Qin H; Chang CS; Ren M; Cowell JK; Hu T
    Int J Cancer; 2020 Apr; 146(8):2243-2254. PubMed ID: 31525277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome.
    Xiao S; Nalabolu SR; Aster JC; Ma J; Abruzzo L; Jaffe ES; Stone R; Weissman SM; Hudson TJ; Fletcher JA
    Nat Genet; 1998 Jan; 18(1):84-7. PubMed ID: 9425908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZNF198, a zinc finger protein rearranged in myeloproliferative disease, localizes to the PML nuclear bodies and interacts with SUMO-1 and PML.
    Kunapuli P; Kasyapa CS; Chin SF; Caldas C; Cowell JK
    Exp Cell Res; 2006 Nov; 312(19):3739-51. PubMed ID: 17027752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.